Join the Canadian SADS Foundation for the 34th episode of Let’s Talk SADS Live with Dr. Andrew Landstrom, as we explore the promise and progress of gene therapy for inherited arrhythmia syndromes.

This episode will dive into how gene therapies are being developed to treat conditions such as Long QT Syndrome, CPVT, and Brugada Syndrome, and what this means for families affected by SADS. From understanding how these therapies work to what’s on the horizon in clinical research, Dr. Landstrom will help break down the science and share insights into what the future may hold.

Dr. Andrew Landstrom is an Associate Professor of Pediatrics and Cell Biology at Duke University School of Medicine. He specializes in pediatric cardiology and electrophysiology, with a focus on inherited arrhythmia syndromes. In addition to his clinical work, Dr. Landstrom leads research exploring the genetic and molecular causes of sudden cardiac death in children and young adults, bridging patient care with cutting-edge genomic science.

This episode of Let’s Talk SADS Live explores gene therapy for SADS conditions and what it could mean for individuals and families living with a genetic heart rhythm disorder.